Fairvalue-Calculator Fairvalue-Calculator
EN DE

AppYea, Inc (APYP) Fair Value & Analysis

Technology · US · Market cap $10.3M

Price$0.0100
Fair Value$0.0100
Upside+0.0%
Quality95/100
Evidence: Low Range $0.0100 – $0.0100

Fair value as of: Jun 26, 2026

Analysis

AppYea, Inc (APYP) currently trades at $0.0100, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. The company offers wristband, with the AppySleep app. AppYea, Inc. was founded in 2012 and is based in Jerusalem, Israel.

Open the full interactive analysis →

Similar stocks

SAP SE (SAPP34) -29% Salesforce, Inc (CRM) +19% Uber Technologies, Inc (UBER) +51% Shopify Inc (SHOP) -81% ServiceNow, Inc (NOW) -72% Cadence Design Systems, Inc (CDNS) -79%

Frequently asked questions

Is AppYea, Inc (APYP) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0100 versus a price of $0.0100 — about +0% (undervalued). Model-based estimate, not financial advice.
What is the fair value of APYP?
Our 21-model fair value for AppYea, Inc is $0.0100 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0100.
What is the quality score of APYP?
AppYea, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.